Capital International Sarl Abb Vie Inc. Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital International Sarl holds 83,822 shares of ABBV stock, worth $14.7 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

83,822

Previous 80,164 4.56%

Holding current value

$14.7 Million

Previous $13.7 Million 20.39%

% of portfolio

0.45%

Previous 0.44%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $599,326 - $729,149	3,658 Added 4.56%	83,822 $16.6 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $875,492 - $1.02 Million	5,656 Added 7.59%	80,164 $13.7 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $7.08 Million - $8.06 Million	44,286 Added 146.54%	74,508 $13.6 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $118,748 - $133,739	863 Added 2.94%	30,222 $4.68 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $700,011 - $810,366	-5,240 Reduced 15.14%	29,359 $4.38 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $30,874 - $38,421	233 Added 0.68%	34,599 $4.66 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $2 Million - $2.3 Million	13,816 Added 67.23%	34,366 $5.48 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $420,739 - $504,576	3,042 Added 17.37%	20,550 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $418,600 - $480,107	3,119 Added 21.68%	17,508 $2.35 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $510,707 - $649,276	-3,711 Reduced 20.5%	14,389 $2.2 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2.39 Million - $2.96 Million	18,100 New	18,100 $2.93 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $2.61 Million - $3.95 Million	-40,390 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $991,935 - $1.19 Million	-15,750 Reduced 28.05%	40,390 $3.06 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $197,100 - $251,940	-3,000 Reduced 5.07%	56,140 $4.08 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $825,398 - $971,453	-10,700 Reduced 15.32%	59,140 $4.77 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $3.11 Million - $3.46 Million	34,990 Added 100.4%	69,840 $0
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.12 Million - $3.42 Million	34,850	34,850 $3.37 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Abb Vie Inc. Transaction History